XPH
State Street SPDR S&P Pharmaceuticals ETF
stockNYSEETF
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 66.89 | 2026-09-28 | -4.80% | 1.221 |
| 1M | 70.93 | 2026-09-04 | -10.22% | 0.850 |
| 3M | 67.28 | 2026-07-06 | -5.35% | 0.564 |
| 6M | 54.35 | 2026-04-06 | +17.17% | 0.589 |
| 1Y | 48.63 | 2025-10-06 | +30.95% | 0.775 |
| 2Y | 44.54 | 2024-10-04 | +42.97% | — |
| 5Y | 46.85 | 2021-10-05 | +35.92% | 0.762 |
State Street SPDR S&P Pharmaceuticals ETF (NYSE:XPH) stock price today is $63.68, and today's volume is 312,539. XPH is down 0.157% today. The 30 day average volume is 189,064. XPH market cap is $525.38M with 8.25M shares outstanding.